Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility Study

NCT05653193 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER_GOV

Sponsor class

Conditions

Chronic Pulmonary Aspergillosis
Aspergillosis

Interventions

DRUG: Interferon Gamma-1B 0.1 MG Per 0.5 ML Injection PLUS antifungals as standard of care
DRUG: Antifungals as standard of care

Sponsor

Manchester University NHS Foundation Trust